Results 1 to 10 of about 2,602,735 (305)

Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage [PDF]

open access: yesStroke, 2019
Author(s): Bower, Matthew M; Sweidan, Alexander J; Shafie, Mohammad; Atallah, Steven; Groysman, Leonid I; Yu ...
Matthew Bower   +2 more
exaly   +6 more sources

Severe Hemorrhage Associated With Oral Anticoagulants [PDF]

open access: yesDeutsches Ärzteblatt international, 2020
Few data have been published to date on outcomes after the common clinical experience of severe hemorrhage in orally anticoagulated patients.A prospective, multicenter observational study was carried out to investigate outcomes and management in a series of consecutive patients who sustained a severe hemorrhage under treatment with vitamin K ...
Edelgard, Lindhoff-Last   +14 more
openaire   +3 more sources

Oral myiasis in brain hemorrhage

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2018
Myiasis is a rare condition which arises from the invasion of body tissues or cavities of living animals or humans by maggots or larvae of certain species of flies. Oral myiasis is seen especially in individuals with neurologic deficit, secondary to oral
Ekta Parmar   +3 more
doaj   +2 more sources

Risk of intraocular hemorrhage with new oral anticoagulants [PDF]

open access: yesEye, 2016
PurposeTo assess the risk of intraocular hemorrhage with warfarin and new oral anticoagulants (NOACs).MethodsWe ascertained all reported cases of intraocular hemorrhage (vitreous, choroidal, or retinal) with warfarin and NOACs (including dabigatran, rivaroxaban, apixaban) from the World Health Organizations's Vigibase database from 1968-2015. We used a
G, Talany, M, Guo, M, Etminan
openaire   +3 more sources

Intracranial hemorrhage in the era of the “direct” oral anticoagulants [PDF]

open access: yesRomanian Journal of Neurology, 2019
Intracranial hemorrhage (ICH) is the most severe complication in patients treated with oral anticoagulants (OACs). Duration of anticoagulant therapy and poor anticoagulation control are important factors for hemorrhagic risk.
Ileana Raluca Nistor, Leonida Gherasim
doaj   +2 more sources

Management of intractable oronasal bleeding using Sengstaken-Blakemore tubes in patients with facial trauma: a case series and technical notes [PDF]

open access: yesClinical and Experimental Emergency Medicine, 2021
Objective Intractable massive oronasal bleeding can become a life-threatening condition. The success rate of conventional bleeding control methods other than transarterial embolization (TAE) is not expected to be high.
Gi Woon Kim   +5 more
doaj   +1 more source

Transcatheter arterial chemoembolization is safe and effective for patients with late-stage or recurrent oral carcinoma

open access: yesFrontiers in Oncology, 2022
ObjectiveWe reported the long-term outcomes of transcatheter chemoembolization (TACE) for patients with late-stage or recurrent oral carcinoma.MethodsThis retrospective study enrolled 18 patients with late-stage or recurrent oral carcinoma between ...
Yonghua Bi   +7 more
doaj   +1 more source

Evaluation of Direct Oral Anticoagulant Reversal Agents in Intracranial Hemorrhage

open access: yesJAMA Network Open, 2022
Key Points Question What outcomes are associated with direct oral anticoagulant (DOAC) reversal agents in intracranial hemorrhage (ICH)? Findings In a meta-analysis of 32 studies including 1832 patients with ICH, 4-factor prothrombin complex concentrate (
R. Chaudhary   +19 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy